Drugs

Acknowledgement

Can a New Ultra-Long-Acting Insulin Analogue Improve Patient Care? Investigating the Potential Role of Insulin Degludec

Jennifer D. Robinson, Joshua J. Neumiller, R. Keith Campbell

US Food and Drug Administration’s Risk Evaluation and Mitigation Strategy for Extended-Release and Long-Acting Opioids

Sebastiano Mercadante, David Craig, Antonello Giarratano

Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel Disease

Guru Trikudanathan, Preethi G. K. Venkatesh, Udayakumar Navaneethan

Optimal Use of Treprostinil in Pulmonary Arterial Hypertension

Nika Skoro-Sajer

Primary Prevention of Major Cardiovascular and Cerebrovascular Events with Statins in Diabetic Patients

Folgerdiena M. de Vries, Petra Denig, Koen B. Pouwels, Maarten J. Postma, Eelko Hak

Axitinib

Lily P. H. Yang, Kate McKeage

Adalimumab

Celeste B. Burness, Emma D. Deeks

Ingenol Mebutate Gel 0.015% and 0.05%

Gillian M. Keating

Meningococcal Quadrivalent (Serogroups A, C, W135 and Y) Tetanus Toxoid Conjugate Vaccine (Nimenrix™)

Jamie D. Croxtall, Sohita Dhillon

Boceprevir

Karly P. Garnock-Jones